ZS Pharma, Inc. 4
4 · ZS Pharma, Inc. · Filed Dec 21, 2015
Insider Transaction Report
Form 4
ZS Pharma, Inc.ZSPH
Farrow Jeffrey S
Chief Financial Officer
Transactions
- Disposition to Issuer
Employee Stock Option (NQ)
2015-12-17−77,900→ 0 totalExercise: $56.31From: 2016-07-08Exp: 2025-07-07→ Common Stock (77,900 underlying) - Disposition to Issuer
Employee Stock Option (ISO)
2015-12-17−7,100→ 0 totalExercise: $56.31From: 2016-07-08Exp: 2025-07-07→ Common Stock (7,100 underlying)